Australian researchers achieve a breakthrough in improving breast cancer cure rates, offering new hope for patients worldwide ...

Several factors, including histopathologic subtypes of liver metastases, tumor-infiltrating lymphocyte (TIL) enrichment, and molecular subtypes, may help guide the identification of candidates for ...

The makers released the teaser with the caption, “Witness the appearance of the most ferocious, the half-man, half-lion Avatar, Lord Vishnu’s most powerful incarnation.” High on visual ...

Umoja Biopharma announced a $100 million Series C round that will help the Seattle-based company further develop its CAR T-cell immunotherapy treatments for cancer. Umoja is developing a multi ...

Get Instant Summarized Text (Gist) A phase 1 clinical trial indicates that a new off-the-shelf immunotherapy using CAR-NK cells shows promise for treating B-cell lymphomas. This approach, derived ...

R-5780, an oral immuno-oncology drug designed to activate gut-regulated immune pathways, will now be evaluated in a phase 1 trial for cancer treatment. The FDA has accepted the investigational new ...

Results showed that overall survival at two years reached 82.2 per cent in patients receiving Durvalumab, compared to 75.2 per cent in those who did not. The final-stage phase three clinical trial ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. Patients with advanced bladder cancer treated with an ...

Each of these mechanisms (Figure 1) contributes to the overall effectiveness of CAR-Macrophages in targeting and eliminating cancer cells, making them a promising therapeutic approach in cancer ...

Other 2025 highlights include "The Bad Guys 2," "Dog Man," "The SpongeBob Movie: Search for Square Pants," "The Magnificent Life of Marcel Pagnol," "The Twits," and possibly "Wildwood." It’s ...